|Reactivity||Human, Mouse, Monkey|
|Dilution||IHC-P (10 µg/ml)|
|Other Names||Potassium voltage-gated channel subfamily H member 2, Eag homolog, Ether-a-go-go-related gene potassium channel 1, ERG-1, Eag-related protein 1, Ether-a-go-go-related protein 1, H-ERG, hERG-1, hERG1, Voltage-gated potassium channel subunit Kv11.1, KCNH2, ERG, ERG1, HERG|
|Target/Specificity||Human KCNH2 / Kv11.1. BLAST analysis of the peptide immunogen showed no homology with other human proteins.|
|Reconstitution & Storage||Long term: -70°C; Short term: +4°C|
|Precautions||KCNH2 / HERG Antibody (Internal) is for research use only and not for use in diagnostic or therapeutic procedures.|
|Synonyms||ERG, ERG1, HERG|
|Function||Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Channel properties are modulated by cAMP and subunit assembly. Mediates the rapidly activating component of the delayed rectifying potassium current in heart (IKr) (PubMed:18559421, PubMed:26363003, PubMed:27916661).|
|Cellular Location||Cell membrane; Multi- pass membrane protein|
|Tissue Location||Highly expressed in heart and brain. Isoforms USO are frequently overexpressed in cancer cells|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
firstname.lastname@example.org, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Pore-forming (alpha) subunit of voltage-gated inwardly rectifying potassium channel. Channel properties are modulated by cAMP and subunit assembly. Mediates the rapidly activating component of the delayed rectifying potassium current in heart (IKr). Isoforms USO have no channel activity by themself, but modulates channel characteristics by forming heterotetramers with other isoforms which are retained intracellularly and undergo ubiquitin-dependent degradation.
Warmke J.W.,et al.Proc. Natl. Acad. Sci. U.S.A. 91:3438-3442(1994).
Itoh T.,et al.Hum. Genet. 102:435-439(1998).
Soejima H.,et al.Genomics 74:115-120(2001).
Downie D.,et al.Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
Crociani O.,et al.J. Biol. Chem. 278:2947-2955(2003).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at email@example.com.